C92.30
Myeloid sarcoma, not having achieved remission
Clinical Classification Guidelines
Inclusion Terms
- Myeloid sarcoma with failed remission
- Myeloid sarcoma NOS
Medical Intelligence & Overview
Myeloid sarcoma, also known as granulocytic sarcoma or chloroma, is a rare type of cancer that involves the formation of tumor masses made up of immature myeloid cells outside the bone marrow. When it is described as not having achieved remission, it indicates that the disease persists despite treatment efforts. This condition is classified under ICD-10 code C92.30 and requires careful medical management due to its aggressive nature.
Causes & Symptoms
Clinical Causes: It is primarily associated with certain types of leukemia, particularly acute myeloid leukemia (AML). Somatic mutations in genes that control blood cell growth may contribute to the development of myeloid sarcoma. Previous treatment failure or resistance to chemotherapy or other therapies can result in persistent disease. In some cases, myeloid sarcoma may develop without a prior diagnosis of leukemia or other blood disorders.
Key Symptoms: A noticeable swelling or lump in the skin, gums, bones, or other soft tissues. Pain or tenderness in the affected area. Unexplained weight loss and fatigue. Fever or night sweats. Potential signs of leukemia such as anemia, easy bruising, or frequent infections. Localized symptoms depending on the tumor's location, such as vision changes if involving the eye.
Diagnostic & Treatment
Diagnosis Path: Accurate diagnosis involves a combination of clinical evaluation, imaging studies, and tissue biopsy. A biopsy of the tumor mass allows for microscopic examination and immunohistochemistry testing to confirm the presence of immature myeloid cells. Blood tests may reveal abnormalities typical of leukemia, such as abnormal white blood cell counts. Bone marrow examinations are often performed to assess disease involvement and determine disease status. Imaging techniques like MRI, PET scans, or CT scans help in identifying the extent of tumor spread.
Treatment Protocols: Management of myeloid sarcoma that has not achieved remission typically involves a multidisciplinary approach, including chemotherapy, radiation therapy, and possibly stem cell transplantation. options include: - Chemotherapy regimens similar to those used for AML to target and eliminate malignant cells. - Radiation therapy aimed at shrinking localized tumor masses or alleviating symptoms. - Stem cell or bone marrow transplantation may be considered to replace diseased marrow with healthy cells. - Targeted therapies or clinical trials could also be options in refractory cases. The treatment plan depends on various factors, including the patient’s overall health, disease progression, and the response to initial treatments.
Clinical Advice & FAQs
Billing Guidance
Is C92.30 a billable ICD-10 code?
Yes, C92.30 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C92.30?
Clinical documentation must specify the nature of Myeloid sarcoma, not having achieved remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference